Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 453.00
+9.00 (2.03%)
Oct 1, 2026, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 172.65 billion as of October 1, 2026. Its market cap has decreased by -48.66% in one year.
Market Cap
172.65B
Enterprise Value
174.62B
Revenue
21.42B
Ranking
n/a
PE Ratio
162.53
Stock Price
453.00
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 172.65B, an increase of 512,146.11%. That is a compound annual growth rate of 267.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 172.65B | -14.62% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 368.85B |
| Wockhardt | 338.62B |
| Piramal Pharma | 274.52B |
| Alivus Life Sciences | 168.67B |
| Eris Lifesciences | 165.07B |
| Alembic Pharmaceuticals | 162.25B |
| NATCO Pharma | 147.10B |
| Sudeep Pharma | 135.52B |